Form 8-K - Current report:
SEC Accession No. 0000950123-11-015571
Filing Date
2011-02-18
Accepted
2011-02-18 13:26:16
Documents
2
Period of Report
2011-02-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y04568e8vk.htm 8-K 10821
2 EX-99.1 y04568exv99w1.htm EX-99.1 12504
  Complete submission text file 0000950123-11-015571.txt   25077
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 11623735
SIC: 2836 Biological Products, (No Diagnostic Substances)